Abstract
Almost 14% of patients defined as particularly vulnerable to adverse drug events were prescribed one or more high risk drugs. The composite indicator of high risk prescribing used could identify practices as having above average or below average high risk prescribing rates with reasonable confidence. After adjustment, only the number of drugs prescribed long term to patients was strongly associated with high risk prescribing, and considerable unexplained variation existed between practices. High risk prescribing will often be appropriate, but the large variation between practices suggests opportunities for improvement.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | d3514 |
Journal | British Medical Journal |
Volume | 342 |
DOIs | |
Publication status | Published - 2011 |